keyword
https://read.qxmd.com/read/38631492/naja-nigricincta-nigricincta-venom-a-murine-model-evaluation-of-skeletal-and-cardio-myonecrosis-kidney-injury-and-inflammatory-response-along-with-neutralisation-efficacy-by-the-saimr-savp-and-echitab-plus-icp-polyvalent-antivenoms
#1
JOURNAL ARTICLE
Esta L Saaiman Engelbrecht, Vinny Naidoo, Christo J Botha
African spitting cobra, Naja nigricincta nigricincta (Zebra snake), envenomation is an important cause of snakebite morbidity and mortality in Namibia. The snake is endemic to central and northern Namibia as well as southern Angola. The venom is mainly cytotoxic, resulting in aggressive dermo-necrosis and often accompanied by severe systemic complications. No specific antivenom exists. Rhabdomyolysis, systemic inflammatory response, haemostatic abnormalities, infective necrotising fasciitis as well as acute kidney failure have been documented...
April 15, 2024: Toxicon: Official Journal of the International Society on Toxinology
https://read.qxmd.com/read/38612610/pelvic-organ-prolapse-reconstruction-with-the-chitosan-based-novel-haemostatic-agent-in-ovine-model-preliminary-report
#2
JOURNAL ARTICLE
Klaudia Stangel-Wójcikiewicz, Maciej Murawski, Tomasz Schwarz, Krzysztof Skotniczny, Agnieszka Fuchs, Jan Wolski, Julia Radwan-Pragłowska, Łukasz Janus, Marek Piątkowski, Marta Kot, Andrzej Wróbel, Dorota Wojtysiak, Przemysław Urbaniec
This prospective study aimed to assess the feasibility of chitosan biomaterial and subcutaneous gel implantation in an ovine model, with implications for women with genital prolapse. Twenty-four ewes were divided into four groups (n = 6 per group): chitosan type B, chitosan type C, chitosan unmodified injections, and polypropylene mesh. Ovine models were chosen due to their morphological resemblance to human reproductive organs. Animals were sacrificed after 90 days for macroscopic, pathomorphological, and immunohistochemical analysis...
March 28, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38606945/the-benefits-of-gene-therapy-in-people-with-haemophilia
#3
REVIEW
Courtney D Thornburg
Haemophilia is an inherited bleeding disorder which causes significant morbidity and mortality, especially in the severe form. Prophylaxis with factor replacement has high efficacy in reducing bleeding but is limited by the need for frequent intravenous infusion and fluctuations in haemostasis between doses. Additional prophylaxis therapies are being developed which may overcome some of the current treatment barriers. Gene therapy (GT) is being developed to provide a functional cure such that there is sustained factor expression and minimal to no need for additional haemostatic therapy...
April 2024: Journal of Viral Hepatitis
https://read.qxmd.com/read/38595024/aluminium-in-dermatology-inside-story-of-an-innocuous-metal
#4
REVIEW
Aravind Baskar Murthy, Vijayasankar Palaniappan, Kaliaperumal Karthikeyan
Aluminium, the third most abundant element in the earth's crust, was long considered virtually innocuous to humans but has gained importance in the recent past. Aluminium is ubiquitous in the environment, with various sources of exposure like cosmetics, the food industry, occupational industries, the medical field, transport and electronics. Aluminium finds its utility in various aspects of dermatology as an effective haemostatic agent, anti-perspirant and astringent. Aluminium has a pivotal role to play in wound healing, calciphylaxis, photodynamic therapy and vaccine immunotherapy with diagnostic importance in Finn chamber patch testing and confocal microscopy...
February 9, 2024: Indian Journal of Dermatology, Venereology and Leprology
https://read.qxmd.com/read/38585752/exploring-ligands-that-target-von-willebrand-factor-selectively-under-oxidizing-conditions-through-docking-and-molecular-dynamics-simulations
#5
Gianluca Interlandi
The blood protein von Willebrand factor (VWF) is a large multimeric protein that, when activated, binds to blood platelets tethering them to the site of vascular injury initiating blood coagulation. This process is critical for the normal haemostatic response, but especially under inflammatory conditions it is thought to be a major player in pathological thrombus formation. For this reason, VWF has been the target for the development of anti-thrombotic therapeutics. However, it is challenging to prevent pathological thrombus formation while still allowing normal physiological blood coagulation as currently available anti-thrombotic therapeutics are known to cause unwanted bleeding in particular intracranial haemorrhage...
March 27, 2024: bioRxiv
https://read.qxmd.com/read/38583717/multicenter-evaluation-of-the-haemostatic-activity-of-emicizumab-in-patients-with-severe-haemophilia-a
#6
JOURNAL ARTICLE
Laurie Josset, Alexandre Leuci, Maissaa Janbain, Anaëlle De-Wreede, Stephanie Desage, Anne Lienhart, Valérie Bin, Dorothée Lambert, Xavier Delavenne, Yesim Dargaud
BACKGROUND: Emicizumab has been approved for the prophylaxis of patients with hemophilia A with or without inhibitors. However, spontaneous and trauma-induced breakthrough bleeds have been reported in patients on emicizumab prophylaxis and no laboratory assay is validated to evaluate the hemostatic activity of emicizumab . OBJECTIVES: The thrombin generation assay (TGA) could be a surrogate marker of the hemostatic efficacy of emicizumab. The correlation between TGA and the methods used to measure emicizumab blood concentration was evaluated in this study...
April 5, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38571337/dental-management-of-people-with-complex-or-rare-inherited-bleeding-disorders
#7
JOURNAL ARTICLE
Lochana Nanayakkara, Norjehan Yahaya, Miryam Parreira, Branislav Bajkin
Advances in haematological therapies for people with complex or rare inherited bleeding disorders (IBD) have resulted in them living longer, retaining their natural teeth with greater expectations of function and aesthetics. Dental management strategies need to evolve to meet these challenges. Utilising low level laser diode therapy to reduce pre-operative inflammation to reduce the intraoperative and postoperative burden on haemostasis is described in a case series of 12 patients. For these individuals who previously required further medical management to support haemostasis or experienced such prolonged haemorrhage sufficient to warrant hospital admission, haemostasis was achieved in the dental surgery such that they were able to return home with no further medical intervention or overnight stays...
April 3, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38567679/clinical-guideline-on-reversal-of-direct-oral-anticoagulants-in-patients-with-life-threatening-bleeding
#8
JOURNAL ARTICLE
Oliver Grottke, Arash Afshari, Aamer Ahmed, Eleni Arnaoutoglou, Daniel Bolliger, Christian Fenger-Eriksen, Christian von Heymann
BACKGROUND: Anticoagulation is essential for the treatment and prevention of thromboembolic events. Current guidelines recommend direct oral anticoagulants (DOACs) over vitamin K antagonists in DOAC-eligible patients. The major complication of anticoagulation is serious or life-threatening haemorrhage, which may necessitate prompt haemostatic intervention. Reversal of DOACs may also be required for patients in need of urgent invasive procedures. This guideline from the European Society of Anaesthesiology and Intensive Care (ESAIC) aims to provide evidence-based recommendations and suggestions on how to manage patients on DOACs undergoing urgent or emergency procedures including the treatment of DOAC-induced bleeding...
May 1, 2024: European Journal of Anaesthesiology
https://read.qxmd.com/read/38565933/risk-of-post-operative-bleeding-after-dentoalveolar-surgery-in-patients-taking-anticoagulants-a-cohort-study-using-the-common-data-model
#9
JOURNAL ARTICLE
Joo-Yeon Lee, Seung-Hyun Park, Da-Mi Kim, Kyung-A Ko, Jin-Young Park, Jung-Seok Lee, Ui-Won Jung, Jae-Kook Cha
This retrospective study aimed to determine risk factors associated with post-operative bleeding after dentoalveolar surgery in patients taking anticoagulants. Patients taking anticoagulants who were planned to undergo periodontal flap operation, tooth extraction or implant surgery were included. Patients were divided into two subgroups according to the maintenance of anticoagulants following medical consultation: (1) maintenance group and (2) discontinuation group. The analysed patient-related factors included systemic diseases, maintenance of anticoagulants and types of anticoagulant...
April 2, 2024: Scientific Reports
https://read.qxmd.com/read/38562457/modifying-platelets-at-their-birth-anti-thrombotic-therapy-without-haemorrhage
#10
REVIEW
Conor Feely, Nitika Kaushal, Pier Paolo D'Avino, John Martin
Cardiovascular disease is a leading cause of death. The current approach to the prevention of arterial thrombosis in cardiovascular disease is dependent on the use of therapies which inhibit the activation of platelets. Predictably these are associated with an increased risk of haemorrhage which causes significant morbidity. The thrombotic potential of an activated platelet is modifiable; being determined before thrombopoiesis. Increased megakaryocyte ploidy is associated with larger and more active platelets carrying an increased risk of thrombosis...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38562115/-not-available
#11
JOURNAL ARTICLE
Andreas Tiede, Sophie Susen, Ton Lisman
Acquired bleeding disorders can develop in previously healthy people irrespective of age or gender but are particularly common in patients with certain underlying conditions. Here, we review recent advances in the management of acquired haemophilia A (AHA), acquired von Willebrand syndrome (AVWS), and patients with hemostatic abnormalities due to chronic liver disease (CLD). Patients with AHA can now benefit from prophylaxis with emicizumab, a therapeutic antibody that mimics the function of activated coagulation factor VIII...
April 2, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38556579/thromboembolic-events-after-major-bleeding-events-in-patients-with-mechanical-heart-valves-a-13-year-analysis
#12
JOURNAL ARTICLE
Pascal Augustin, Stefan Andrei, Bernard Iung, Marylou Para, Peter Matthews, Christian de Tymowski, Nadine Ajzenberg, Philippe Montravers
Anticoagulation in patients with mechanical heart valves (MHV) is associated with a risk of major bleeding episodes (MBE). In case of MBE, anticoagulant interruption is advocated. However, there is lack of data regarding the thrombo-embolic events (TE) risk associated with anticoagulant interruption. The main objective of the study was to evaluate the rate and risk factors of 6-months of TEs in patients with MHV experiencing MBE. This observational study was conducted over a 13-year period. Adult patients with a MHV presenting with a MBE were included...
March 31, 2024: Journal of Thrombosis and Thrombolysis
https://read.qxmd.com/read/38549723/early-gastro-oesophageal-junction-perforation-repaired-using-through-the-scope-clips-following-nissen-fundoplication
#13
Phelopatir Anthony, Nagy Andrawis
Early gastric and oesophageal perforations are rare following laparoscopic fundoplications, with an incidence of 0.9%. If managed operatively, omentopexy or redo-fundoplication may be employed. Here, we present the case of a septic 21 year old patient who presented with an early gastro-oesophageal perforation 7 days following laparoscopic Nissen fundoplication, which was successfully repaired endoscopically using haemostatic clips. To date, this technique of perforation repair in the setting of fundoplication has yet to be reported...
March 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38543074/synthetic-haemostatic-sealants-effectiveness-safety-and-in-vivo-applications
#14
JOURNAL ARTICLE
Federica Curcio, Paolo Perri, Paolo Piro, Stefania Galassi, Roberta Sole, Sonia Trombino, Roberta Cassano
Rapid haemostasis during surgery is essential when one wants to reduce the duration of operations, reduce the need for transfusions, and above all when one wants to achieve better patient management. The use of haemostatic agents, sealants, and adhesives improves the haemostatic process by offering several advantages, especially in vascular surgery. These agents vary widely in their mechanism of action, composition, ease of application, adhesion to wet or dry tissue, immunogenicity, and cost. The most used are cyanoacrylate-based glues (Glubran 2) or polysaccharide hydrogel-microsphere powder (AristaTM AH)...
February 23, 2024: Pharmaceuticals
https://read.qxmd.com/read/38523253/the-effects-of-emicizumab-on-in-vitro-coagulation-and-fibrinolysis-parameters-in-patients-with-disseminated-intravascular-coagulation-with-and-without-addition-of-anti-fviii-antibody
#15
JOURNAL ARTICLE
Tomoko Onishi, Hanako Shimo, Suguru Harada, Keiji Nogami
BACKGROUND: Emicizumab (Emi) is used as haemostatic prophylaxis for patients with haemophilia A (PwHA). Disseminated intravascular coagulation (DIC) is a condition characterized by persistent systemic activation of coagulation, but there is yet no information on coagulation and fibrinolysis potentials in Emi-treated PwHA with DIC. AIM: To examine the effect of Emi on coagulation and fibrinolysis potentials in HA-model DIC plasmas. METHODS: Plasma from a patient with sepsis-DIC (seven patients) was treated with anti-factor (F)VIII monoclonal antibody (HA-model DIC plasma) and incubated with Emi (50 µg/mL)...
March 24, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38521192/mathematical-models-of-coagulation-are-we-there-yet
#16
JOURNAL ARTICLE
Matt J Owen, Joy R Wright, Edward G D Tuddenham, John R King, Alison H Goodall, Joanne L Dunster
BACKGROUND: Mathematical models of coagulation have been developed to mirror thrombin generation in plasma, with the aim of investigating how variation in coagulation factor levels regulate haemostasis. However, current models vary in the reactions they capture, in reaction rates used, and their validation is restricted by a lack of large coherent datasets, resulting in questioning of their utility. OBJECTIVES AND METHODS: To address this debate, we systematically assessed current models against a large dataset, using plasma coagulation factor levels from 348 individuals with normal haemostasis as inputs, and compared model predictions with measured thrombin generation...
March 21, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38518896/standardisation-of-definition-and-management-for-bleeding-disorder-of-unknown-cause-communication-from-the-ssc-of-the-isth
#17
Ross I Baker, Philip Choi, Nicola Curry, Johanna Gebhart, Keith Gomez, Yvonne Henskens, Floor Heubel-Moenen, Paula James, Rezan Abdul Kadir, Peter Kouides, Michelle Lavin, Marie Lordkipanidze, Gillian Lowe, Andrew Mumford, Nicola Mutch, Michael Nagler, Maha Othman, Ingrid Pabinger, Robert Sidonio, Will Thomas, James S O'Donnell
In many patients referred with significant bleeding phenotype, laboratory testing fails to define any hemostatic abnormalities. Clinical practise with respect to diagnosis and management of this patient cohort poses significant clinical challenges. We recommend that bleeding history in these patients should be objectively assessed using the ISTH bleeding assessment tool (BAT). Patients with increased BAT scores should progress to hemostasis laboratory testing. To diagnose BDUC, normal complete blood count, prothrombin time, activated partial thromboplastin time, thrombin time, von Willebrand factor antigen, von Willebrand factor function; coagulation factors VIII, IX and XI and platelet light transmission aggregometry (LTA) should be the minimum laboratory assessment...
March 20, 2024: Journal of Thrombosis and Haemostasis: JTH
https://read.qxmd.com/read/38494792/cryogel-wound-dressings-based-on-natural-polysaccharides-perfectly-adhere-to-irregular-wounds-for-rapid-haemostasis-and-easy-disassembly
#18
JOURNAL ARTICLE
Changchun Liu, Jiaqi Liu, Minmin Wu, Haifeng Ni, Jie Feng, Liping Zhao, Jing Zhang
Skin injuries can have unexpected surfaces, leading to uneven wound surfaces and inadequate dressing contact with these irregular surfaces. This can decrease the dressing's haemostatic action and increase the healing period. This study recommends the use of sticky and flexible cryogel coverings to promote faster haemostasis and efficiently handle uneven skin wounds. Alginate cryogels have a fast haemostatic effect and shape flexibility due to their macroporous structure. The material demonstrates potent antibacterial characteristics and enhances skin adherence by adding grafted chitosan with gallic acid...
March 17, 2024: Wound Repair and Regeneration
https://read.qxmd.com/read/38481077/benefits-and-risks-of-non-factor-therapies-redefining-haemophilia-treatment-goals-in-the-era-of-new-technologies
#19
JOURNAL ARTICLE
Maria Elisa Mancuso, Stacy E Croteau, Robert Klamroth
INTRODUCTION: Over the last decades progress in haemophilia treatment has been remarkable and prophylaxis with clotting factor concentrates in haemophilia A and B has been established as the standard of care in individuals with haemophilia and a severe bleeding phenotype. Besides clotting factor products with prolonged half-life non-factor therapies were developed which enable prophylaxis via subcutaneous administration. Factor VIIIa mimetics like emicizumab facilitate the coagulation pathway and are used in routine clinical practice for indivdiduals with haemophilia A...
March 13, 2024: Haemophilia: the Official Journal of the World Federation of Hemophilia
https://read.qxmd.com/read/38458629/learning-curve-of-achieving-competency-in-emergency-endoscopy-in-upper-gastrointestinal-bleeding-how-much-experience-is-necessary
#20
JOURNAL ARTICLE
Gabriel Allo, Sonja Lang, Anna Martin, Martin Bürger, Xinlian Zhang, Seung-Hun Chon, Dirk Nierhoff, Ulrich Töx, Tobias Goeser, Philipp Kasper
OBJECTIVES: The management of upper gastrointestinal bleeding (UGIB) has seen rapid advancements with revolutionising innovations. However, insufficient data exist on the necessary number of emergency endoscopies needed to achieve competency in haemostatic interventions. DESIGN: We retrospectively analysed all oesophagogastroduodenoscopies with signs of recent haemorrhage performed between 2015 and 2022 at our university hospital. A learning curve was created by plotting the number of previously performed oesophagogastroduodenoscopies with signs of recent haemorrhage against the treatment failure rate, defined as failed haemostasis, rebleeding and necessary surgical or radiological intervention...
March 7, 2024: BMJ Open Gastroenterology
keyword
keyword
170712
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.